Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 994 entries
View as:

Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement

Phase: N/A Priority: Normal
NCT ID: NCT02576652 Org: User:
Start: 12/22/15 End: 12/18/17 Due: 12/18/18

Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03465540 Org: User:
Start: 08/17/18 End: 07/25/19 Due: 07/25/20

Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout

Phase: N/A Priority: Normal
NCT ID: NCT03994731 Org: User:
Start: 06/13/19 End: 04/11/22 Due: 04/11/23

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

Phase: N/A Priority: Normal
NCT ID: NCT02747043 Org: User:
Start: 05/25/16 End: 06/28/19 Due: 06/28/20

Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab

Phase: N/A Priority: Normal
NCT ID: NCT02304484 Org: User:
Start: 11/24/14 End: 03/09/18 Due: 03/09/19

A Study to Evaluate the Pharmacokinetic Exposure of 2 Formulations of Apremilast in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02777554 Org: User:
Start: 08/17/16 End: 11/22/16 Due: 11/22/17

Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT01439867 Org: User:
Start: 06/22/12 End: 06/03/16 Due: 06/03/17

European Physician Survey of EGFR Inhibitor Prescribing Patterns

Phase: N/A Priority: Normal
NCT ID: NCT01652833 Org: User:
Start: 03/31/12 End: 11/30/14 Due: 11/30/15

Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06898957 Org: User:
Start: 05/30/25 End: 04/13/31 Due: 04/13/32

Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00091793 Org: User:
Start: 08/31/04 End: 03/31/09 Due: 03/31/10

Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00332332 Org: User:
Start: 03/31/06 End: 02/28/10 Due: 02/28/11

Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01740297 Org: User:
Start: 02/07/13 End: 03/09/21 Due: 03/09/22

A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06131398 Org: User:
Start: 03/07/24 End: 12/22/28 Due: 12/22/29

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Phase: N/A Priority: Normal
NCT ID: NCT07005128 Org: User:
Start: 06/20/25 End: 07/15/29 Due: 07/15/30

A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03287908 Org: User:
Start: 11/13/17 End: 06/30/23 Due: 06/30/24

Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

Phase: N/A Priority: Normal
NCT ID: NCT06321601 Org: User:
Start: 10/22/24 End: 07/20/30 Due: 07/20/31

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00975000 Org: User:
Start: 12/03/09 End: 04/16/13 Due: 04/16/14

A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT02443506 Org: User:
Start: 10/31/04 End: 06/30/07 Due: 06/30/08

Enbrel® in Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00111124 Org: User:
Start: - End: - Due: -

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Phase: N/A Priority: Normal
NCT ID: NCT00975221 Org: User:
Start: 03/10/10 End: 12/21/12 Due: 12/21/13

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01380756 Org: User:
Start: 10/04/11 End: 09/04/14 Due: 09/04/15

A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02961881 Org: User:
Start: 09/18/17 End: 09/02/21 Due: 09/02/22

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02307513 Org: User:
Start: 12/30/14 End: 07/17/20 Due: 07/17/21

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00120679 Org: User:
Start: 10/31/02 End: 12/31/03 Due: 12/31/04

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT01444417 Org: User:
Start: 01/31/12 End: 02/28/15 Due: 02/28/16